PACAP- and PHI-mediated sustained relaxation in circular muscle of gastric fundus: findings obtained in PACAP knockout mice

Regul Pept. 2006 Jan 15;133(1-3):54-61. doi: 10.1016/j.regpep.2005.09.019. Epub 2005 Oct 17.

Abstract

Mediators of neurogenic responses of the gastric fundus were studied in wild type and pituitary adenylate cyclase activating peptide (PACAP) knockout mice. Electrical field stimulation (EFS) to the circular muscle strips of the wild type mouse fundus induced a tri-phasic response, rapid transient contraction and relaxation, and sustained relaxation that was prolonged for an extended period after the end of EFS. The transient relaxation and contraction were completely inhibited by N(G)-nitro-L-arginine and atropine, respectively. The sustained relaxation was completely inhibited by a PACAP receptors antagonist, PACAP(6-38). The strips prepared from PACAP knockout mice exhibited a large contraction without rapid relaxation and unexpectedly, a sustained relaxation. However, the sustained relaxation was decreased to about a half of that observed in wild type mice. Anti-peptide histidine isoleucine (PHI) serum abolished the sustained relaxation in the knockout mice. The serum partially inhibited the sustained relaxation in wild type mice and PACAP(6-38) abolished the relaxation that remained after the antiserum-treatment. PHI relaxed the strips prepared from wild type mice. The relaxation was completely inhibited by PACAP(6-38). It was concluded that PACAP and PHI separately mediate the sustained relaxation in the mouse gastric fundus, and that nitric oxide and ACh mediate transient relaxation and contraction, respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Electric Stimulation
  • Female
  • Gastric Fundus / drug effects
  • Gastric Fundus / physiology*
  • Male
  • Mice
  • Mice, Knockout
  • Muscle Contraction / drug effects
  • Muscle Contraction / physiology
  • Muscle Relaxation / drug effects*
  • Muscle Relaxation / physiology
  • Neurotransmitter Agents / metabolism
  • Neurotransmitter Agents / pharmacology
  • Peptide Fragments / antagonists & inhibitors
  • Peptide Fragments / metabolism
  • Peptide PHI / metabolism
  • Peptide PHI / pharmacology*
  • Pituitary Adenylate Cyclase-Activating Polypeptide / antagonists & inhibitors
  • Pituitary Adenylate Cyclase-Activating Polypeptide / genetics
  • Pituitary Adenylate Cyclase-Activating Polypeptide / metabolism
  • Pituitary Adenylate Cyclase-Activating Polypeptide / pharmacology*
  • Vasoactive Intestinal Peptide / metabolism

Substances

  • Neurotransmitter Agents
  • Peptide Fragments
  • Peptide PHI
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • pituitary adenylate-cyclase-activating-peptide (6-38)
  • Vasoactive Intestinal Peptide